Previous Article | Next Article ![]()
Infect. Immun., 04 1995, 1415-1420, Vol 63, No. 4
FR Rurangirwa, A Wambugu, SM Kihara and TC McGuire
Monoclonal antibody (MAb) WM-25 differentiates by in vitro growth
inhibition Mycoplasma capricolum subsp. capripneumoniae (Mycoplasma strain
F38), which causes contagious carpine pleuropneumonia, from other
Mycoplasma spp. (F. R. Rurangirwa, T. C. McGuire, A. J. Musoke, and A.
Kibor, Infect. Immun. 55:3219-3220, 1987). The antigen identified by MAb
WM-25 was isolated from solubilized Mycoplasma strain F38 organisms by MAb
WM-25 affinity chromatography and was stained with Schiff's reagent, but
not with Coomassie blue, after separation by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. Treatment of purified F38
polysaccharide with periodate abolished binding with MAb WM-25, and MAb
WM-25 binding was blocked with laminarin, a complex oligosaccharide with
beta(1-->3) sugar linkages. Purified F38 polysaccharide blocked both
growth inhibition and agglutination of live F38 organisms caused by MAb
WM-25 and rabbit antiserum to F38 organisms. The results in this paper
demonstrate that MAb WM-25 binds a periodate-sensitive epitope on the F38
polysaccharide which is also exposed on the surface of Mycoplasma strain
F38. Because MAb WM-25 also causes in vitro growth inhibition of F38, the
reactive polysaccharide epitope may induce protective immune responses.
Copyright © 1995, American Society for Microbiology
A Mycoplasma strain F38 growth-inhibiting monoclonal antibody (WM-25) identifies an epitope on a surface-exposed polysaccharide antigen
Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washinton State University, Pullman 99164-7040.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|